ASMBS and ASGE issue white paper on endoscopic bariatric therapies (EBTs)

November 17, 2011

The American Society for Gastrointestinal Endoscopy (ASGE) and the American Society for Metabolic & Bariatric Surgery (ASMBS) have issued a new white paper on the potential role of endoscopic bariatric therapies (EBTs) in treating obesity and obesity-related diseases like Type 2 diabetes.

The entitled, "A Pathway to Endoscopic Bariatric Therapies," appears online in both GIE: , the peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE) and Surgery for Obesity and Related Diseases (SOARD), the peer-reviewed scientific journal of the American Society for Metabolic & Bariatric Surgery (ASMBS).

"The two societies formed a joint task force to identify opportunities where endoscopic treatments may play a role in improving patient outcomes and reducing costs," said Gregory G. Ginsberg, MD, FASGE, ASGE president and chair of the ASGE/ASMBS Task Force on EBT. "The white paper establishes the criteria for success as new technologies and procedures are developed."

According to the white paper, several EBTs are currently in different stages of development and include a wide variety of methods to induce and reduce obesity-related diseases and conditions.

EBTs are performed entirely through the gastrointestinal tract using thin flexible endoscopes and may offer patients an outpatient alternative to bariatric procedures including laparoscopic gastric bypass, adjustable gastric banding and sleeve gastrectomy.

"Endoscopic therapy has the potential to be applied across the continuum of obesity and metabolic disease," said Bipan Chand, MD, chairman, ASMBS Emerging Technology and Procedure Committee, and co-chair of the ASGE/ASMBS Task Force. "However, it is generally expected that endoscopic modalities achieve weight loss superior to that produced by medical and intensive lifestyle interventions, have a favorable risk/benefit profile and have scientific evidence to support its use."

The white paper addresses endoscopic bariatric therapy treatment classification, potential indications, and efficacy including: primary efficacy endpoints such as weight loss, definitions for weight loss, comparison of weight loss between therapies, threshold for weight loss, and study design; and secondary efficacy endpoints such as reduction in obesity-related co-morbidities, changes in quality of life, safety, durability and repeatability, adoption of EBTs in the context of global patient care, endoscopy unit considerations, training and credentialing, cost effectiveness, and government and industry relations.

To read the full white paper, log on to GIE: Gastrointestinal Endoscopy online at www.giejournal.org or see the November print issue; or see the ASMBS journal, Surgery for Obesity and Related Diseases http://asmbs.org/soard/.

According to the Centers for Disease Control and Prevention (CDC), about one-third of U.S. adults (33.8 percent) are obese. Medical costs associated with obesity are about $147 billion or 10 percent of all medical spending, double what it was a decade ago. The ASMBS estimates there are 17 million people in the U.S. with morbid obesity (BMI of 40 or more, or a BMI of 35 or more with an obesity-related disease).

Obesity is a disease that contributes to more than 30 other obesity related diseases and conditions that include Type 2 diabetes, hypertension, heart disease, sleep apnea and certain cancers.

Bariatric surgery has been shown to be the most effective and long lasting treatment for obesity and many related conditions. Studies have shown patients may lose 30 to 50 percent of their excess weight 6 months after surgery and 77 percent of their excess weight as early as one year after surgery. The Agency for Healthcare Research and Quality (AHRQ) reported significant improvements in the safety of bariatric surgery over the last several years due in large part to improved laparoscopic techniques and the advent of bariatric surgical centers of excellence. The overall risk of death from bariatric is about 0.1 percent and the risk of major complications is about 4 percent.

Explore further: Number of laparoscopic bariatric procedures continued to rise between 2003-2008

Related Stories

Number of laparoscopic bariatric procedures continued to rise between 2003-2008

August 8, 2011
According to a study published in the August issue of the Journal of the American College of Surgeons, there was an increase in the number of laparoscopic bariatric procedures, an increase in the number of bariatric surgeons ...

Weight-loss surgery cost-effective for all obese

July 14, 2011
(Medical Xpress) -- Bariatric surgery is not only cost-effective for treating people who are severely obese, but also for those who are mildly obese, according to a new study from Washington University School of Medicine ...

Recommended for you

Concerns that sleep apnea could impact healthspan

July 27, 2017
The number of people with obstructive sleep apnea has steadily increased over the past two decades. The disorder, which causes a person to briefly stop breathing when asleep, affects over 100 million people globally and is ...

Anti-nausea drug could help treat sleep apnea

June 6, 2017
An old pharmaceutical product may be a new treatment for obstructive sleep apnea, according to new research presented today by University of Illinois at Chicago and Northwestern University scientists at the SLEEP 2017 annual ...

New disposable, wearable patch found to effectively detect sleep apnea

June 4, 2017
Results of a definitive clinical trial show that a new, disposable diagnostic patch effectively detects obstructive sleep apnea across all severity levels.

Childhood sleep apnoea is common but hard to diagnose

April 28, 2017
The cessation of breathing during sleep caused by enlarged tonsils is common in preschool-age children and can cause serious complications, but the methods normally used to diagnose the condition are subjective and unreliable. ...

Curbing sleep apnea might mean fewer night trips to bathroom

March 27, 2017
(HealthDay)—Millions of Americans battle bothersome nighttime conditions, such as sleep apnea or the need to get up frequently to urinate.

Untreated sleep apnea in children can harm brain cells tied to cognition and mood

March 17, 2017
A study comparing children between 7 and 11 years of age who have moderate or severe obstructive sleep apnea to children the same age who slept normally, found significant reductions of gray matter - brain cells involved ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.